Allogene Therapeutics, Inc. (ALLO)
2.20
-0.13
(-5.58%)
USD |
NASDAQ |
May 14, 11:34
Allogene Therapeutics Free Cash Flow : -149.63M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agenus, Inc. | -87.53M |
| Inovio Pharmaceuticals, Inc. | -88.92M |
| Vaxart, Inc. | 14.80M |
| Capricor Therapeutics, Inc. | -81.54M |
| Curis, Inc. | -27.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.60M |
| Cash from Investing (Quarterly) | 33.61M |
| Cash from Financing (Quarterly) | 7.859M |
| Free Cash Flow Per Share (Quarterly) | -0.1221 |
| Free Cash Flow to Equity (Quarterly) | -25.71M |
| Free Cash Flow to Firm (Quarterly) | -27.29M |
| Free Cash Flow Yield | -30.83% |